Composite Endpoints in Hypertrophic Cardiomyopathy

被引：1

作者：

Ommen, Steve R. ^{[1
,2
]}

机构：

[1] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA

[2] Mayo Clin, 200 First St SW, Rochester, MN 55905 USA

来源：

JACC-HEART FAILURE | 2023年 / 11卷 / 01期

关键词：

hypertrophic cardiomyopathy; outcomes; risk assessment; DISEASE;

D O I：

10.1016/j.jchf.2022.10.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：42 / 43

页数：2

共 4 条

[1] Comparison of Demographic, Clinical , Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis A Network Meta-Analysis [J].

Georgiopoulos, Georgios ;

Figliozzi, Stefano ;

Pateras, Konstantinos ;

Nicoli, Flavia ;

Bampatsias, Dimitrios ;

Beltrami, Matteo ;

Finocchiaro, Gherardo ;

Chiribiri, Amedeo ;

Masci, Pier Giorgio ;

Olivotto, Iacopo .

JACC-HEART FAILURE, 2023, 11 (01) :30-41

[2] Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe) [J].

Ho, Carolyn Y. ;

Day, Sharlene M. ;

Ashley, Euan A. ;

Michels, Michelle ;

Pereira, Alexandre C. ;

Jacoby, Daniel ;

Cirino, Allison L. ;

Fox, Jonathan C. ;

Lakdawala, Neal K. ;

Ware, James S. ;

Caleshu, Colleen A. ;

Helms, Adam S. ;

Colan, Steven D. ;

Girolami, Francesca ;

Cecchi, Franco ;

Seidman, Christine E. ;

Sajeev, Gautam ;

Signorovitch, James ;

Green, Eric M. ;

Olivotto, Iacopo .

CIRCULATION, 2018, 138 (14) :1387-1398

[3] How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality Shaped by 50 Years of Clinical Research and Practice [J].

Maron, Barry J. ;

Rowin, Ethan J. ;

Casey, Susan A. ;

Maron, Martin S. .

JAMA CARDIOLOGY, 2016, 1 (01) :98-105

[4]

Ommen SR, 2020, J AM COLL CARDIOL, V76, pE159, DOI 10.1016/j.jacc.2020.08.045

← 1 →